Novacyt admission and first day of dealings AIM ENG
Paris, France and Cambridge, UK – 1st November 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the admission of the Company’s Shares (the “Enlarged Share Capital”) to trading on AIM, a market operated by the London Stock Exchange (“AIM Admission”), from 8:00 a.m. (GMT) today under the ticker “NCYT” (ISIN: FR0010397232).